Add BrightSurf on Google Email

Lasker Foundation announces 2026 Lasker Award winners

The Lasker Foundation has announced the 2026 Lasker Award winners, honoring fundamental discoveries in sleep research, revolutionary therapy for hemophilia A, and leadership in Parkinson’s disease research advocacy. Emmanuel Mignot and Masashi Yanagisawa will receive the Albert Lasker Basic Medical Research Award for discovering orexin...

Nanoparticles induce neuroregeneration in Alzheimer’s disease models

Researchers develop a polymer nanogel system called Nano-ERASER that uses antibodies to degrade targeted proteins, inducing neuron regeneration and restoring neural circuits in human brain organoids and mice with Alzheimer's disease. The study provides a critical step in regenerative neuroscience, offering a roadmap for a potential cure.

SourceCell Press·JournalCell Biomaterials·TypeExperimental study·DateAug 26, 2026

Critical Path for Parkinson’s announces milestone publication highlighting FDA support for novel biomarker to advance precision medicine strategies

The publication of the alpha-synuclein seed amplification assay (αSyn-SAA) biomarker highlights a decade of collaborative progress in biomarker development. This milestone enables earlier testing of new treatments for Parkinson's disease, which could delay or prevent disease onset and progression.

New uOttawa study suggests gene linked to Parkinson's disease holds clues to battling deadly bacterial infections

Researchers have discovered a gene linked to Parkinson's disease may also strengthen the body's ability to fight dangerous infections. The study found that a well-studied mutation in the LRRK2 gene increases the production of reactive oxygen species, making immune cells more effective at eliminating intracellular bacteria.

SourceUniversity of Ottawa·JournalCellular and Molecular Immunology·TypeImaging analysis·DateAug 19, 2026

Towards better detection of lifelong difficulties in face processing using a screening questionnaire

A study confirms the 20-item prosopagnosia index questionnaire is an effective screening tool for detecting developmental prosopagnosia, a condition where individuals struggle to recognize familiar faces. The researchers also identified opportunities for refinement to improve the questionnaire's accuracy.

SourceJapan Advanced Institute of Science and Technology·JournalBehavior Research Methods·TypeSurvey·DateAug 19, 2026

Sound evaluation of stiffness: Using acoustic tweezers to analyze biomolecular droplets

Researchers from the University of Osaka developed an analytical tool called acoustic tweezers to investigate the mechanical properties of biopolymer condensates. The study found that changes in the natural movement of a droplet in solution can provide information on the stiffness of the droplet and the state of the molecules inside.

SourceThe University of Osaka·JournalPRX Life·TypeExperimental study·DateAug 17, 2026

Youth-associated protein helps restore healthy function in immune cells in the aging brain

Researchers identified TIMP2 as a key factor supporting healthy microglial function in the aging brain. Restoring TIMP2 in aged mice improved microglia's ability to clear debris and reduced inflammation, suggesting potential therapeutic strategies for neurodegenerative disorders.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalNature Communications·TypeExperimental study·DateAug 14, 2026

Flexing new hope: Muscles may help protect the Parkinson's brain

Researchers found that exercise-induced molecular changes contribute to neuronal health, improving movement and quality of life in PD patients. Exercise types such as aerobic exercises, resistance training, balance training, and multimodal exercise were found to be helpful in reducing falls, disabilities, and improving brain function.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalNeuroprotection·TypeLiterature review·DateAug 7, 2026

Study uses living human brain tissue to map how electric stimulation affects neurons, genetic activity

Researchers used real human brain tissue samples to test the underlying mechanisms of deep brain stimulation. They found that brain cells became more synchronized in communicating, similar to memory formation, while altering gene expression across different types of brain cells.

SourceUniversity of California - Los Angeles Health Sciences·JournalNature·TypeExperimental study·DateAug 5, 2026

Boston University professors receive $2.8 million NIH grant to launch Center on Demography and Economics of Alzheimer’s Disease and Related Dementias

The Boston University-Quantitative Population Science and Healthy Cognitive Aging Research Program (BU-SHARP) aims to better understand how and why Alzheimer's disease manifests among certain populations. The center will fund pilot studies, provide technical assistance, and facilitate access to underutilized datasets.

New University of Minnesota research identifies potential therapeutic target for Alzheimer’s disease

Researchers have identified a new type of brain plaque, called mitochondrial plaques, that may emerge at the earliest stages of Alzheimer's disease. These plaques contain high levels of amyloid precursor protein and can directly affect neurons, making them a potential target for new treatments.

SourceUniversity of Minnesota Medical School·JournalNature Neuroscience·TypeObservational study·DateJul 30, 2026

Genetic base editing treats Huntington’s disease in mice

Researchers at the University of Illinois developed a gene editing tool to treat Huntington's disease by altering a specific point in the huntingtin gene. The treatment reduced toxic protein fragments, symptoms, and brain degeneration in mice, providing a new approach for treating genetic diseases.

SourceUniversity of Illinois at Urbana-Champaign, News Bureau·JournalNature Biomedical Engineering·TypeExperimental study·DateJul 29, 2026

Universidad Carlos III de Madrid and Hospital Universitario Severo Ochoa advance a new methodology based on artificial intelligence and sleep analysis to facilitate the early diagnosis of Alzheimer's

Researchers developed a new methodology using artificial intelligence to analyze brain electrical activity during sleep, identifying early neural alterations and classifying patients into distinct biological subgroups. This non-invasive approach may facilitate earlier diagnosis of Alzheimer's disease.

SourceUniversidad Carlos III de Madrid·JournalGeroScience·DateJul 22, 2026

Kansas City University review highlights astrocytes as key drivers of chronic traumatic encephalopathy

A scoping review suggests astrocytic dysfunction may precede neuronal degeneration in CTE. Astrocytes' dysregulation contributes to the development of CTE's characteristic features through mechanisms including astrogliosis, disrupted waste clearance pathways, and chronic neuroinflammation.

SourceChinese Neurosurgical Journal·JournalChinese Neurosurgical Journal·TypeLiterature review·DateJul 15, 2026

Dementia risk factors look different around the world, large USC study finds

A large USC study of over 214,000 older adults across 14 countries found that controllable dementia risk factors such as low education and high blood pressure differ significantly from country to country. The study's findings suggest a one-size-fits-all approach to prevention may not be effective everywhere, and highlight the importanc...

SourceUniversity of Southern California·JournalThe Lancet Healthy Longevity·TypeData/statistical analysis·DateJul 12, 2026

Data presented at ISSCR 2026 highlight progress toward personalized stem cell therapy for Parkinson’s disease

Researchers at ISSCR 2026 present interim clinical findings from the first Phase 1/2a trial of autologous iPSC-derived dopamine neuron precursor cells for Parkinson's disease. The approach uses each patient's own cells, and new genomic quality control methods ensure the manufactured cells are suitable for transplantation.